EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Management of Bullous Pemphigoid and Norwegian Scabies with Dupilumab Plus Ivermectin

Yanli Zhang, Yuting Liu, Hengan Yi

The American Journal of Tropical Medicine and Hygiene · 04.11.2026 · 115 (5) · 1058-1062

DOI: 10.4269/ajtmh.26-0186 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 04.11.2026. Verfasst von Yanli Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Third People's Hospital of Longgang, Clinical Institute of Shantou University Medical College (The Third People's Hosp…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antiparasitic Agents, Ivermectin. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bullous pemphigoid is a severe autoimmune blistering disease, and Norwegian scabies is a rare comorbidity. However, conventional treatment methods, such as systemic corticosteroids, carry a high risk in the treatment of elderly patients. Herein, this rare comorbidity is described in an elderly patient. After an initial induction treatment with a low-to-moderate dose of corticosteroid, this patient achieved complete remission with a combination therapy of dupilumab (a monoclonal antibody targeting the interleukin-4/13 signaling pathway) and ivermectin. Therefore, the successful treatment of this rare case provides a promising strategy for reducing reliance on corticosteroids in high-risk populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntiparasitic AgentsIvermectinPemphigoid, BullousScabiesHumansMaleDrug Therapy, CombinationNorwayAged

Substanzen

Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntiparasitic AgentsdupilumabIvermectin

Autor:innen und Institutionen

  • Department of Dermatology, The Third People's Hospital of Longgang, Clinical Institute of Shantou University Medical College (The Third People's Hospital of Longgang District Shenzhen), Shenzhen, China.
  • Department of Dermatology, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University), Shenzhen, China.
  • Department of Dermatology, Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen, China.

Zitieren

APA

Zhang, Y., Liu, Y., & Yi, H. (2026). Management of Bullous Pemphigoid and Norwegian Scabies with Dupilumab Plus Ivermectin. The American Journal of Tropical Medicine and Hygiene, 115(5), 1058-1062. https://doi.org/10.4269/ajtmh.26-0186

Vancouver

Zhang Y, Liu Y, Yi H. Management of Bullous Pemphigoid and Norwegian Scabies with Dupilumab Plus Ivermectin. The American Journal of Tropical Medicine and Hygiene. 2026;115(5):1058-1062. doi:10.4269/ajtmh.26-0186

BibTeX
@article{Zhang2026,
  author = {Zhang, Yanli and Liu, Yuting and Yi, Hengan},
  title = {Management of Bullous Pemphigoid and Norwegian Scabies with Dupilumab Plus Ivermectin},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2026},
  volume = {115},
  number = {5},
  pages = {1058--1062},
  doi = {10.4269/ajtmh.26-0186}
}
Kostenlos starten →